Foundation Medicine, Pfizer Announce Partnership To Develop Companion Diagnostics For Pfizer’S Oncology Portfolio
Jan 16 (Reuters) - Foundation Medicine Inc
Latest Developments forPfizer Inc
- Pfizer CEO Hopes Trump Administration Reconsiders Plan To Base Medicare Part B Drug Prices On Cheaper Prices Paid Outside U.S.
- Pfizer Inc announces complete results from Phase 3 Study evaluating efficacy, safety of subcutaneous administration of Tanezumab
- Pfizer Inc Says Board Approved New Compensation Arrangements For Albert Bourla
- Pfizer Granted FDA Breakthrough Therapy Designation For 20-Valent Pneumococcal Conjugate Vaccine